Gene · 1859
Papers3,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| R-loop resolution by ARIP4 helicase promotes androgen-mediated transcription induction. | Sci Adv | 2024 | 39028815 | Swiss-Prot, curated | PubMed |
| DEAD box RNA helicases are pervasive protein kinase interactors and activators. | Genome Res | 2024 | 38986579 | PubTator, text mining | PubMed |
| Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system. | Sci Transl Med | 2024 | 38985854 | PubTator, text mining | PubMed |
| Author Correction: Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs. | NPJ Precis Oncol | 2024 | 38977910 | PubTator, text mining | PubMed |
| Novel splicing variant and gonadal mosaicism in DYRK1A gene identified by whole-genome sequencing in multiplex autism spectrum disorder families. | Neurogenetics | 2024 | 38976082 | PubTator, text mining | PubMed |
| Nuclear F-actin assembly on damaged chromatin is regulated by DYRK1A and Spir1 phosphorylation. | Nucleic Acids Res | 2024 | 38966995 | PubTator, text mining | PubMed |
| Human Cytomegalovirus Dysregulates Cellular Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases and Sonic Hedgehog Pathway Proteins in Neural Astrocyte and Placental Models. | Viruses | 2024 | 38932210 | PubTator, text mining | PubMed |
| DYRK1A signalling synchronizes the mitochondrial import pathways for metabolic rewiring. | Nat Commun | 2024 | 38902238 | PubTator, text mining | PubMed |
| N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents. | Cancers (Basel) | 2024 | 38893153 | PubTator, text mining | PubMed |
| Synthesis of novel hybrids of 1,2,3-triazoles-hydrazone: targeting cholinesterases and Alzheimer's related genes. | Future Med Chem | 2024 | 38864182 | PubTator, text mining | PubMed |
| Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs. | NPJ Precis Oncol | 2024 | 38839871 | PubTator, text mining | PubMed |
| Select DYRK1A Inhibitors Enhance Both Proliferation and Differentiation in Human Pancreatic Beta Cells. | bioRxiv | 2024 | 38798411 | PubTator, text mining | PubMed |
| Regulation of brain development by the Minibrain/Rala signaling network. | bioRxiv | 2024 | 38766038 | PubTator, text mining | PubMed |
| Unraveling the mechanistic interplay of mediators orchestrating the neuroprotective potential of harmine. | Pharmacol Rep | 2024 | 38758470 | PubTator, text mining | PubMed |
| Discovery of a novel chemotype as DYRK1A inhibitors against Alzheimer's disease: Computational modeling and biological evaluation. | Int J Biol Macromol | 2024 | 38704072 | PubTator, text mining | PubMed |
| Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy. | Pharmaceutics | 2024 | 38675189 | PubTator, text mining | PubMed |
| Dual-specificity tyrosine phosphorylation-regulated kinase 1A promotes the inclusion of amyloid precursor protein exon 7. | Biochem Pharmacol | 2024 | 38663682 | PubTator, text mining | PubMed |
| MicroRNA-298 determines the radio-resistance of colorectal cancer cells by directly targeting human dual-specificity tyrosine(Y)-regulated kinase 1A. | World J Gastrointest Oncol | 2024 | 38660649 | PubTator, text mining | PubMed |
| The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection. | J Virol | 2024 | 38651897 | PubTator, text mining | PubMed |
| Psychoplastogenic DYRK1A Inhibitors with Therapeutic Effects Relevant to Alzheimer's Disease. | J Med Chem | 2024 | 38648167 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1859/papers?page=12